These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7685454)

  • 1. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of semotiadil fumarate, a novel calcium antagonist, on blood pressure and heart rate in conscious spontaneously hypertensive rats.
    Kanda A; Hashimoto H
    Jpn J Pharmacol; 1993 Sep; 63(1):121-4. PubMed ID: 8271524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
    Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
    Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.
    Kurokawa M; Sato F; Fujiwara I; Hatano N; Honda Y; Yoshida T; Naruto S; Mastumoto J; Uno H
    J Med Chem; 1991 Mar; 34(3):927-34. PubMed ID: 2002473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive effect of felodipine, a new calcium antagonist].
    Inoue T; Omosu M; Hayashi S; Sakaguchi S; Nakao K; Inukai T; Odagiri N; Ono T
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):453-62. PubMed ID: 1464403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the long-lasting antihypertensive action of 7-O-ethylfangchinoline.
    Kato T; Noguchi K; Sakanashi M
    Jpn J Pharmacol; 1994 Sep; 66(1):35-46. PubMed ID: 7861666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro.
    Okamura H; Fujitani B; Furukawa K; Une T; Nukuda T; Komiya M; Kurokawa M
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):804-9. PubMed ID: 7509897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N; Ikezono K; Mori T; Yamashita S; Nakayama S; Tanaka Y; Hosokawa T; Minami Y; Masutani K; Yamamura Y
    J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.